Related Experiment Video
Updated: Jan 24, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
LncRNA-MEG3 inhibits cell proliferation and invasion by modulating Bmi1/RNF2 in cholangiocarcinoma
Jinglin Li1, Xingming Jiang1, Chunlong Li1
1Department of HPB Surgery, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China.
Abstract:
Cholangiocarcinoma (CCA) is a mortal cancer with gradually increasing incidences all over the world, whereas effective diagnosis and treatment for this disease are still lacking. As a classical long noncoding RNA (lncRNA), maternally expressed gene 3 (MEG3) has been reported to exhibit pivotal regulatory roles in the occurrence and development of various digestive system tumors. Nevertheless, the clinical relevance and biological function of MEG3 in CCA remain largely unclear. In this study, MEG3 expression was significantly downregulated in both CCA tissues and cells in comparison with that in nontumor controls, respectively, and this downexpression was prominently associated with advanced TNM stage, lymph node invasion, and poor survival. Moreover, decreased MEG3 was an independent forecaster of poor prognosis for CCA patients. Functionally, MEG3 overexpression inhibited CCA growth in vitro and in vivo. Enhanced MEG3 also suppressed migration and invasion of CCLP-1 and QBC939 cells by reversing epithelial-mesenchymal transition (EMT) process. On the contrary, the proliferation, metastasis, and EMT were facilitated via knocking down MEG3. In addition, the expression of B lymphoma Mo-MLV insertion region 1 (Bmi1) and RING finger protein 2 was impacted by gain or loss of MEG3, furthermore, the malignant processes induced by MEG3 knockdown were rescued by means of silencing Bmi1. These data suggested that MEG3 caused tumor suppressive effects partly through mediating polycomb repressive complex 1. Our findings elucidate that MEG3 exerts critical functions in CCA development and likely acts as a promising tumor indicator or intervention target for CCA.
Insights
Maternally expressed gene 3 (MEG3) is downregulated in cholangiocarcinoma (CCA), a bile duct cancer. Restoring MEG3 suppresses CCA growth and metastasis, suggesting it's a potential therapeutic target.
Area of Science:
- Molecular Oncology
- Cancer Biology
- Long Noncoding RNAs
Background:
- Cholangiocarcinoma (CCA) incidence is rising globally, with limited effective treatments.
- Maternally expressed gene 3 (MEG3), a long noncoding RNA (lncRNA), plays roles in digestive system tumors.
- The clinical significance and function of MEG3 in CCA are not well understood.
Purpose of the Study:
- To investigate the clinical relevance and biological function of MEG3 in cholangiocarcinoma.
- To explore MEG3's potential as a diagnostic marker and therapeutic target for CCA.
Main Methods:
- Analysis of MEG3 expression levels in CCA tissues and cell lines.
- Correlation of MEG3 expression with clinical parameters (TNM stage, lymph node invasion, survival).
- In vitro and in vivo functional assays to assess the impact of MEG3 overexpression or knockdown on CCA cell behavior.
- Investigation of MEG3's interaction with B lymphoma Mo-MLV insertion region 1 (Bmi1) and polycomb repressive complex 1.
Main Results:
- MEG3 expression was significantly downregulated in CCA tissues and cells compared to controls.
- Reduced MEG3 expression correlated with advanced TNM stage, lymph node invasion, and poorer patient survival.
- MEG3 overexpression inhibited CCA cell proliferation, migration, and invasion by reversing epithelial-mesenchymal transition (EMT).
- MEG3 knockdown promoted proliferation, metastasis, and EMT, effects partially mediated by Bmi1.
Conclusions:
- MEG3 acts as a tumor suppressor in cholangiocarcinoma.
- Downregulation of MEG3 is an independent predictor of poor prognosis in CCA patients.
- MEG3 exerts its function partly through the Bmi1-mediated polycomb repressive complex 1 pathway.
- MEG3 holds promise as a diagnostic indicator and therapeutic target for CCA.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Feedback Inhibition
Cells Coordinate Growth and Proliferation
Abnormal Proliferation
Enzyme Inhibition

